Agios Anticipates PK Deficiency Diagnosis Ramp-Up After Pyrukynd Approval

Reimbursement Challenges

 
• By Alaric DeArment
3-D Rendering Red Blood Cells
The FDA approved Agios' Pyrukynd for pyruvate kinase deficiency on 17 February • Source: Shutterstock

More from New Products

More from Scrip